Curis (CRIS) Net Cash Flow (QoQ) (2010 - 2026)
Curis (CRIS) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Curis |
8.37 Mn |
-6.63 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
349.15% |
| Dec 31, 2025 |
-267.07% |
| Sep 30, 2025 |
89.28% |
| Jun 30, 2025 |
-3,659.30% |
| Mar 31, 2025 |
133.26% |
| Dec 31, 2024 |
-107.89% |
| Sep 30, 2024 |
154.40% |
| Jun 30, 2024 |
-709.47% |
| Mar 31, 2024 |
47.99% |
| Dec 31, 2023 |
-51.42% |
| Sep 30, 2023 |
138.36% |
| Jun 30, 2023 |
-198.64% |
| Mar 31, 2023 |
218.10% |
| Dec 31, 2022 |
-145.20% |
| Sep 30, 2022 |
-126.91% |
| Jun 30, 2022 |
171.70% |
| Mar 31, 2022 |
-65.66% |
| Dec 31, 2021 |
41.14% |
| Sep 30, 2021 |
38.63% |
| Jun 30, 2021 |
-93.79% |
